Home/Pipeline/BSEN762

BSEN762

Pruritus

PreclinicalActive

Key Facts

Indication
Pruritus
Phase
Preclinical
Status
Active
Company

About Bsense Bio Therapeutics

Dual‑target small molecules for non‑opioid pain, tinnitus and itch relief.

View full company profile

Therapeutic Areas

Other Pruritus Drugs

DrugCompanyPhase
AV104Avior BioNot Disclosed